FDA Proposes Guidelines to Expedite Cell and Gene Therapy Development

The U.S. FDA has released new draft guidance designed to speed up the development process for cell and gene therapies. This framework details how developers can utilize existing scientific and regulatory data to streamline submissions for gene therapy products involving genome editing. The initiative aims to accelerate patient access to these advanced treatments.